All In Biotech

Drug Trial Radar · NCT07836504

A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.

Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

32

Planned (sponsor's estimate)

Start

Sep 30, 2026

Primary completion

Sep 25, 2027

Study completion Oct 30, 2027

Sponsor

Sponsor type
Industry
First posted
Sep 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a two-part single-center, open-label, parallel, single-dose pharmacokinetic study of HS-10504 in participants with hepatic impairment and normal hepatic function.

Conditions

  • To Compare the Pharmacokinetic (PK) Differences of HS-10504 Between Participants With Hepatic Impairment and Participants With Normal Hepatic Function

Interventions

  • HS-10504Drug

    HS-10504:On Day 1, a single oral dose of 400 mg HS-10504 tablet was administered in the fasting state.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of PK parameters of HS-10504: CmaxTime frame: 216 hours after administration of HS-10504
  2. Evaluation of PK parameters of HS-10504: AUC0-tTime frame: 216 hours after administration of HS-10504
  3. Evaluation of PK parameters of HS-10504: AUC0-∞Time frame: 216 hours after administration of HS-10504

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.